Clinical trials
Enrolling by invitation Anemia, Sickle Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ASH Research Collaborative | 1 |
| Editas Medicine, Inc. | 1 |
| Fulcrum Therapeutics | 1 |
| Genetix Biotherapeutics Inc. | 1 |
| Georgetown University | 1 |
| Mount Sinai Hospital, Canada | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Phoenicia BioScience | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 9 |
| beta-Thalassemia | 4 |
| Hematologic Diseases | 3 |
| Genetic Diseases, Inborn | 2 |
| Hemoglobinopathies | 2 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Congenital | 1 |
| Coronary Artery Disease | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.